• Profile
Close

Clinical relevance of PD-L1 expression in gallbladder cancer: A potential target for therapy

Histopathology Jul 01, 2018

Neyaz A, et al. - Utilizing SP263 clone in tissue microarray, 174 cases of gallbladder carcinoma (GBC) were assessed to study the clinical relevance of program death ligand (PD-L1) expression. It was observed that tumor size, growth pattern, presence of necrosis and lympho-vascular emboli demonstrated no significant relationship with PD-L1 in tumor or tumor infiltrating lymphocytes. It was concluded that PD-L1 did not seem to be a prognostic marker or have an influence on survival in GBC. Data revealed that PD-L1 expression occurs in one of four gallbladder cancers, supporting improving the dismal overall survival with a future probability of immune-modulation therapy.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay